128 related articles for article (PubMed ID: 20701665)
1. Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws.
Fanourakis G; Lazaris AC; Krithinakis S; Tosios KI; Sklavounou A; Tseleni-Balafouta S
J Oral Pathol Med; 2010 Oct; 39(9):687-9. PubMed ID: 20701665
[TBL] [Abstract][Full Text] [Related]
2. [Expression of receptor activator of NF-kappa B ligand and osteoprotegerin protein in the giant cell lesions of jaw].
Meng XM; Yu SF; Wei MJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):294-7. PubMed ID: 16191370
[TBL] [Abstract][Full Text] [Related]
3. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor proteins in peripheral and central giant cell granulomas of the jaws.
Kamel A; Elsharkawy TM
Egypt Dent J; 1995 Jul; 41(3):1243-6. PubMed ID: 9497663
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
[TBL] [Abstract][Full Text] [Related]
7. A comparative immunohistochemical evaluation of CD68 and TRAP protein expression in central and peripheral giant cell granulomas of the jaws.
Torabinia N; Razavi SM; Shokrolahi Z
J Oral Pathol Med; 2011 Apr; 40(4):334-7. PubMed ID: 21029180
[TBL] [Abstract][Full Text] [Related]
8. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.
Andrade FR; Sousa DP; Mendonça EF; Silva TA; Lara VS; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Oct; 106(4):548-55. PubMed ID: 18928898
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts.
de Moraes M; de Lucena HF; de Azevedo PR; Queiroz LM; Costa Ade L
Arch Oral Biol; 2011 Nov; 56(11):1256-63. PubMed ID: 21683340
[TBL] [Abstract][Full Text] [Related]
11. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
12. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of RANKL in oral giant cell lesions is predictive of aggressiveness.
Martini G; Capella D; Rivero ERC; Gondak RO
Braz Oral Res; 2018 Oct; 32():e115. PubMed ID: 30379236
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
15. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma.
Chuang FH; Hsue SS; Wu CW; Chen YK
J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior.
Tobón-Arroyave SI; Hurtado-García P; García-Quintero OD; Isaza-Guzmán DM; Flórez-Moreno GA
J Oral Pathol Med; 2015 Oct; 44(9):752-60. PubMed ID: 25413222
[TBL] [Abstract][Full Text] [Related]
20. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
Byron CR; Barger AM; Stewart AA; Pondenis HC; Fan TM
Am J Vet Res; 2010 Jun; 71(6):615-22. PubMed ID: 20513175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]